CJC-1295
Synthetic GHRH analogue (with or without DAC)
CJC-1295 is a synthetic GHRH analogue investigated in early-phase human pharmacology studies and in GHRH-knockout rodent models. Published primary human research is limited to small Phase I/II pharmacokinetic and pharmacodynamic trials.
Phase I/II human pharmacology and rodent literature